Physician profile
Tamara L Small
NPI 1760618920
$5,681.42
in general payments reported to CMS, 2019-2025
44 companies · $1,029 in 2025
The $1,029 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $748 · 2020: $810 · 2021: $572 · 2022: $563 · 2023: $1,084 · 2024: $875 · 2025: $1,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,944 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,943.69 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,096.49 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $624.14 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $622.39 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Pfizer INC. | $448.18 | 2019-2025 | |
| Abbott Laboratories | $353.00 | 2019-2025 | Proclaim, Eterna, Freestyle Libre 3 |
| Abbvie INC. | $322.19 | 2020-2025 | Vraylar |
| Merck Sharp & Dohme LLC | $197.69 | 2019-2024 | Capvaxive, Gardasil, Gardasil 9 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.48 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $137.21 | 2019-2023 | Shingrix, Bexsero |
| Exact Sciences Corporation | $129.56 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $98.84 | 2019-2025 | Repatha, Otezla |
| Shire North American Group INC | $97.51 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $96.40 | 2020-2022 | |
| Allergan, INC. | $85.75 | 2020 | |
| Seqirus USA INC | $83.22 | 2022-2025 | Fluad, Flucelvax |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Small listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.